Blueprint Medicines Corp DEF 14A Filing
| Field | Detail |
|---|---|
| Company | Blueprint Medicines Corp |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Blueprint Medicines filed its DEF 14A, detailing exec pay for 2024. Check it out.
AI Summary
Blueprint Medicines Corporation filed a DEF 14A on April 24, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key individuals mentioned in relation to compensation tables include members like 'HavilandMember' and 'AlbersMember' for the fiscal years 2020 through 2024.
Why It Matters
This filing provides transparency into the compensation of Blueprint Medicines' top executives and board members, which can influence investor decisions and corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and corporate governance, not indicating immediate financial distress or significant new risks.
Key Numbers
- 2024 — Fiscal Year End (The most recent fiscal year for which compensation details are provided.)
- 2020-2024 — Fiscal Years Covered (The range of fiscal years for which compensation data is presented in the filing.)
Key Players & Entities
- Blueprint Medicines Corp (company) — Filer of the DEF 14A
- HavilandMember (person) — Executive/Board Member referenced in compensation tables
- AlbersMember (person) — Executive/Board Member referenced in compensation tables
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by companies to solicit proxies from shareholders for their annual or special meetings, providing detailed information on matters to be voted upon, including executive compensation, director elections, and other corporate governance issues.
When was this DEF 14A filed by Blueprint Medicines Corp?
This DEF 14A filing was made on April 24, 2025.
What fiscal period does this DEF 14A filing primarily cover?
This DEF 14A filing primarily covers the fiscal year ending December 31, 2024, with comparative data for prior years.
Who are some of the individuals mentioned in the compensation tables?
The filing references individuals identified as 'HavilandMember' and 'AlbersMember' in relation to compensation data for the fiscal years 2020 through 2024.
What is the standard industrial classification for Blueprint Medicines Corp?
The Standard Industrial Classification for Blueprint Medicines Corp is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 by HavilandMember regarding Blueprint Medicines Corp.